MilliporeSigma to Build Two Biodevelopment Facilities in U.S. and China
Millipore will open two new Provantage® End-to-End services centers in Boston and Shanghai. These centers will capitalize on the success of the center in Martillac, France, a fully operational, single-use, GMP facility.
The two facilities will provide a range of process development services, including cell-line, upstream and downstream, and non-GMP clinical production. Provantage services provided by the Martillac facility currently include: biopharma process development, clinical-scale templates, GMP clinical supply solutions, facility design and construction consultation, and process scale-up and technical transfer services.
"We are seeing an increasing global demand for end-to-end process development solutions and MilliporeSigma offers a one-stop shop for biopharma customers," said Udit Batra, CEO. "This expansion reinforces our position as the premier supplier of all process development and clinical stage manufacturing solutions, materials and services needed for the production of biologics. This is a strategic, high-potential investment for MilliporeSigma specifically designed to meet customer needs on three continents."